Profile
AGRX ZTS TAK HLN TEVA ITCI
Company Name Agile Therapeutics, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $10.43M $73.16B $47.84B $46.83B $19.50B $14.05B
Employees 0.02K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Mr. Alfred F. Altomari Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
AGRX ZTS TAK HLN TEVA ITCI
Quant Rating Score 2 3 3 3 1 1
Quant Rating Sell Neutral Neutral Neutral Strong Sell Strong Sell
Trading
AGRX ZTS TAK HLN TEVA ITCI
Last Close $1.51 $157.23 $14.97 $10.5 $17 $131.87
High 52 $1.51 $196.48 $15.39 $11.41 $22.77 $131.91
Low 52 $1.41 $144.45 $12.89 $8.26 $12.82 $67.99
Price vs. 52 Week High 0 % -19.98 % -2.73 % -7.98 % -25.34 % -0.03 %
Price vs. 52 Week Low 7.09 % 8.85 % 16.14 % 27.12 % 32.61 % 93.95 %
Total Return
AGRX ZTS TAK HLN TEVA ITCI
1 Month Return 0 % -3.29 % 2.75 % -5.75 % 0.24 % 0 %
3 Month Return 0 % -3.43 % -0.33 % 4.48 % 8.35 % 0.14 %
6 Month Return 0 % -5.01 % 13.93 % 7.8 % -24.85 % 53.34 %
9 Month Return 0 % -19.32 % 2.18 % -0.85 % -4.17 % 80.13 %
YTD Return 0 % -3.5 % 13.07 % 10.06 % -22.87 % 57.89 %
1 Year Return 4.86 % -8 % 15.87 % 23.53 % 4.62 % 85.5 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AGRX ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.13 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) - 32.25 % 280.28 % - - -
Profitability
AGRX ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 63.99 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM -100.63 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM 93.04 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM 84.82 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 100 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM 157.59 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM -64.1 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM -716.61 % 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM 3.28 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM 0.32 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM 0.93 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM 5285.82 % 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 99.62 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM -0.3 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM -0.3 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 41.54 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM -13.89 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM -716.61 % 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM -5.03 32.07 9.73 - 25.68 -191.12
Price To Operating Cash Flows Ratio TTM -5 24.98 7.13 - 15.4 -185.85
Price Cash Flow Ratio TTM -5 24.98 7.13 - 15.4 -185.85
Income Statement (TTM)
AGRX ZTS TAK HLN TEVA ITCI
Revenue $0.02B $9.26B $4263.76B $11.23B $16.54B $0.68B
Gross Profit $0.01B $6.54B $2832.26B $6.95B $8.06B $0.62B
Gross Profit Ratio 54.18% 70.62% 66.43% 61.85% 48.74% 91.63%
EBITDA $-0.02B $3.87B $874.6B $2.51B $0.72B $-0.12B
Net Income $-0.01B $2.49B $144.07B $1.44B $-1.64B $-0.07B
EPS Diluted -6.71 5.47 45.58 0.32 -1.45 -0.72
Balance Sheet (MRQ)
AGRX ZTS TAK HLN TEVA ITCI
Long Term Debt $0B $5.39B $5029.93B $8.54B $16.3B $0.01B
Total Liabilities $0.03B $9.47B $7834.79B $18.09B $33.61B $0.22B
Total Equity $-0.02B $4.77B $7274.01B $16.22B $5.72B $1.15B
Total Investments $0B $0B $445.7B $0.08B $0B $0.69B
Total Debt $0B $6.74B $4843.75B $10.1B $18.08B $0.02B
Total Assets $0.01B $14.24B $15108.79B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
AGRX ZTS TAK HLN TEVA ITCI
Net Income $-0.01B $2.5B $144.07B $1.44B $-1.96B $-0.07B
Inventory $-0B $-0.04B $-115.74B $0.22B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-287.19B $-0.57B $0B $0B
Operating Cash Flow $-0.01B $2.95B $716.34B $2.3B $1.25B $-0.07B
Capital Expenditure $0B $-0.66B $-480.73B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.255
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AKAN Akanda Corp. 1.43
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.42
ALVOW Alvotech 1.7
AMPH Amphastar Pharmaceuticals, Inc. 23.16
AMRX Amneal Pharmaceuticals, Inc. 8.12
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 65.72
APUS Apimeds Pharmaceuticals US, Inc 1.7183
AQST Aquestive Therapeutics, Inc. 3.255
ASRT Assertio Holdings, Inc. 0.6501
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.28
AYTU Aytu BioPharma, Inc. 2.07
ETFs With Exposure to AGRX
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 133.77
VXF Vanguard Extended Market Index Fund 0 191.48
VQNPX Vanguard Growth and Income Fund 0 65.24
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 106.51
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 143.65
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 143.66
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
VEMPX Vanguard Extended Market Index InstlPlus 0 354.51
Unlock